Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Episode 17 Challenges of developing DMOADs

Why are disease-modifying treatments for osteoarthritis such a difficult proposition?

print
PRINT
insite
SEARCH
Guest:
Prof. Ali Mobasheri
Host:
Dr. Shreeya Nanda

Senior Clinical Content Manager, Springer Medicine

Current treatments for osteoarthritis mostly provide symptomatic relief, and so disease-modifying drugs that target the underlying structural damage would be a game changer. But despite multiple attempts, no DMOAD is yet approved for clinical use.

Prof. Ali Mobasheri takes us through the main challenges, the work being done to address them to make these so-called utopia drugs a reality, and other advances that can offer some hope in the meantime.

« Previous episode: Episode 16: Sexual health in older age

Next episode: Episode 18: The fight for children's eyesight »

print
PRINT

Keynote webinar | Spotlight on advances in lupus

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Learn more about novel biomarkers for diagnosis and monitoring, and familiarize yourself with current and emerging targeted therapies.

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Watch now
Video

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Health+ IME
Learn more
Image Credits
Medicine Matters podcast logo/© Springer Medizin Verlag GmbH, Lupus concept/© (M) Vitalii But / stock.adobe.com / Generated with AI, Aplastic Anemia/© Springer Healthcare IME